BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Consumer Health

Semaglutide Generics, Six Months In: Every Launch in India, Every Price, and Where China Stands

AT A GLANCE 12 generic makers with a public launch in India, selling 20 brands between them Rs 1,290 lowest stated monthly price, for vials...

October 09, 2026 | Analysis

FDA Expands Lilly’s Jaypirca Approval to First-Line CLL/SLL Treatment

Eli Lilly and Company (NYSE: LLY) announced that the U.S. Food and Drug Administration (FDA) has approved an additional indication for Jaypirca (pirto...

October 06, 2026 | News

DKSH Launches Colpofix in Singapore to Support Women with HPV-Related Cervical Lesions

Women in Singapore now have another option to support their cervical health following Human Papillomavirus (HPV) infection, with DKSH's launch of Colpofix&...

September 22, 2026 | News

Kelun-Biotech’s Twice-Yearly Asthma Candidate SKB378 Advances into Phase III

The POLARIS-1 study enrolled 147 patients with uncontrolled, moderate-to-severe asthma, and the interim analysis was conducted on the first 98 patients. ...

September 10, 2026 | News

Nobody Is the Payer

A gerotherapeutic that delays five diseases by three years each would produce savings across five budget lines over thirty years, and a cost that lands in ...

September 04, 2026 | Analysis

Making a Drug People Take for Twenty Years

METHOD IN BRIEF Cost-of-goods figures in this article are reconstructions, not disclosures. No company supplied a cost-of-goods figure and none is...

September 01, 2026 | News

Ascletis Doses First Patient in Global Phase III Programme for Oral GLP-1 Obesity Drug ASC30

- Expected to enroll approximately 4,600 participants with obesity or overweight across two pivotal trials (AURORA-1 and AURORA-2) in the U.S., Europe, and...

September 01, 2026 | News

The Accidental Gerotherapeutic

METHOD IN BRIEF Outcome evidence in this article is taken from published trial results and approved label language only. No efficacy or outcome claim is s...

August 31, 2026 | Analysis

The Biological Age Business

On coming 4th September at six in the evening Singapore time, a public consultation will close. It opened on 7 August, it is still open as this is publishe...

August 27, 2026 | Analysis

Why Asia Pacific Must Rethink Chronic Care Before the Demographic Tipping Point

Asia Pacific’s ageing economies are entering a more demanding phase of healthcare planning. As populations live longer, the challenge for healthcare ...

August 10, 2026 | Opinion | By Ambra Debernardi, Head of Employee Benefits and Corporate Relationships, APAC, Zurich Insurance

Aging Is Not an Indication. Asia-Pacific Found Three Ways Around It.

Feature | Longevity and geroscience | BioPharma APAC The closed front door Start with the fact that shapes everything else. There is no jurisdiction on...

August 07, 2026 | Analysis

Australians Warned Against Buying Unregulated Health Supplements from Overseas

With longevity science gaining global attention and new products rapidly entering the market, overseas supplement retailers are increasingly targeting Aust...

August 06, 2026 | News

Roche Secures US FDA Clearance for PCR Test Detecting Bacterial Vaginosis and Candida Vaginitis

The new PCR test uses clinician-collected or clinician-instructed, self-collected vaginal swab specimens to simultaneously detect organisms associated wi...

July 28, 2026 | News

GHIT Fund Invests JPY 140M to Accelerate Portable Rapid Diagnostic System for Ebola

The Global Health Innovative Technology (GHIT) Fund announced an investment of JPY 140 million (approximately USD 862,000) in a project to develop a portab...

July 24, 2026 | News

Stay Connected